Qiong Luo Selected Research

Hepatocyte Nuclear Factor 3-alpha

3/2016

miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiong Luo Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 01/2014
16	Inflammation (Inflammations) 12/2021 - 10/2008
9	Infections 01/2021 - 03/2013
7	Colitis 12/2019 - 08/2011
6	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 02/2010
6	Birth Weight (Birth Weights) 10/2021 - 12/2018
5	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022 - 07/2018
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2019
5	Pre-Eclampsia (Preeclampsia) 01/2021 - 10/2017
5	Endometriosis 01/2013 - 12/2006
4	Marek Disease (Marek's Disease) 03/2022 - 06/2014
4	Neoplasm Metastasis (Metastasis) 10/2020 - 02/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 03/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 01/2019
3	Thyroid Nodule (Nodule, Thyroid) 03/2021 - 01/2017
3	Pregnancy Complications 01/2020 - 10/2019
3	Wounds and Injuries (Trauma) 01/2020 - 04/2011
3	Contact Dermatitis (Eczema, Contact) 12/2019 - 03/2011
3	Rheumatoid Arthritis 01/2019 - 11/2013
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 01/2016
3	Infertility (Sterility) 05/2010 - 01/2007
2	COVID-19 08/2022 - 01/2020
2	Placenta Previa 01/2022 - 01/2020
2	Gestational Weight Gain 10/2021 - 11/2020
2	Breast Neoplasms (Breast Cancer) 10/2021 - 10/2020
2	Polyhydramnios 05/2021 - 07/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 07/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2021
2	Aneuploidy (Aneuploid) 01/2021 - 06/2010
2	Hemorrhage 03/2020 - 01/2020
2	Venous Thromboembolism 01/2020 - 01/2020
2	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2016
2	Experimental Arthritis 01/2018 - 11/2013
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2017 - 12/2016
2	Sepsis (Septicemia) 09/2016 - 01/2014
2	Hypertension (High Blood Pressure) 01/2016 - 01/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2013 - 03/2013

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2017
6	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2016
5	VaccinesIBA 07/2022 - 06/2014
5	LipidsIBA 01/2022 - 01/2021
5	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2015
5	CytokinesIBA 01/2020 - 03/2013
4	Pharmaceutical PreparationsIBA 01/2022 - 05/2013
4	Therapeutic UsesIBA 01/2022 - 02/2015
3	AntibodiesIBA 08/2022 - 01/2020
3	InflammasomesIBA 01/2022 - 05/2013
3	artenimol (dihydroartemisinin)IBA 01/2022 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2006
3	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 01/2019
3	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2021 - 01/2017
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2021 - 01/2017
3	Picryl Chloride (Trinitrochlorobenzene)IBA 12/2019 - 03/2011
3	NAD (NADH)IBA 01/2019 - 01/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 11/2013
3	LithiumIBA 08/2017 - 12/2016
3	Dextran SulfateIBA 01/2017 - 03/2013
3	thymoquinoneIBA 01/2017 - 01/2016
2	AcidsIBA 10/2022 - 03/2021
2	ORALIT (ORS)IBA 10/2022 - 01/2016
2	8-Hydroxy-2'-DeoxyguanosineIBA 10/2022 - 03/2021
2	Histones (Histone)IBA 01/2022 - 12/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2016
2	Insulin (Novolin)FDA Link 01/2022 - 01/2019
2	Triglycerides (Triacylglycerol)IBA 10/2021 - 01/2021
2	CholesterolIBA 10/2021 - 11/2020
2	AntigensIBA 10/2021 - 01/2015
2	Biological ProductsIBA 05/2021 - 01/2021
2	Guanylate KinasesIBA 05/2021 - 07/2020
2	Epidermal Growth Factor (EGF)IBA 10/2020 - 05/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 06/2012
2	Immune Checkpoint InhibitorsIBA 01/2020 - 12/2019
2	Dihydrotachysterol (AT 10)IBA 01/2020 - 11/2018
2	Fibrinogen (Factor I)FDA Link 01/2020 - 01/2020
2	fibrin fragment D (D-dimer)IBA 01/2020 - 01/2020
2	LigandsIBA 10/2019 - 01/2018
2	CollagenIBA 01/2019 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 01/2017
2	astilbinIBA 01/2018 - 01/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 11/2013
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2007
2	IodineIBA 02/2017 - 01/2017
2	Pilocarpine (Ocusert)FDA LinkGeneric 01/2017 - 12/2016
2	AntioxidantsIBA 01/2017 - 05/2012
2	Polysaccharides (Glycans)IBA 07/2016 - 08/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2010 - 01/2007

Therapy/Procedure

13	Therapeutics 10/2021 - 11/2013
4	Cesarean Section (Caesarean Section) 01/2022 - 01/2020
3	Microbubbles 04/2022 - 01/2019
3	Immunotherapy 01/2022 - 01/2014
3	Length of Stay 01/2021 - 10/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 03/2011
2	Sutures (Suture) 01/2022 - 01/2020
2	Induced Abortion (Induced Abortions) 07/2020 - 01/2007
2	Aftercare (After-Treatment) 01/2020 - 04/2011
2	Oral Administration 03/2013 - 08/2011